Molecular Design and Downstream Processing of Turoctocog Alfa (NovoEight), a B-Domain Truncated Factor VIII Molecule

Blood Coagulation and Fibrinolysis - United States
doi 10.1097/mbc.0000000000000477
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Functional Roles of the Factor VIII B Domain

Haemophilia
MedicineGeneticsHematology
2009English

Factor VIII Assay Variability in Postinfusion Samples Containing Full Length and B-Domain Deleted FVIII

Haemophilia
MedicineGeneticsHematology
2016English

Inhibitory Antibodies Against Factor VIII C1 Domain

Blood
BiochemistryImmunologyCell BiologyHematology
2016English

The Effect of Fluctuating Temperature on the Stability of Turoctocog Alfa for Hemophilia A

Drugs in R and D
Pharmacology
2019English

A Truncated Molecular Star

Chemistry - A European Journal
Organic ChemistryCatalysisChemistry
2017English

Downstream Processing and Bioseparation

ACS Symposium Series
ChemistryChemical Engineering
1990English

Modeling and Applications of Downstream Processing

ACS Symposium Series
ChemistryChemical Engineering
1990English

Reactions to Low-Molecular-Weight Porcine Factor VIII Concentrates.

BMJ
1981English

Pharmacokinetics, Immunogenicity, Safety and Preliminary Efficacy of Subcutaneous Turoctocog Alfa Pegol in Previously Treated Patients With Severe Hemophilia a (Alleviate 1)

Journal of Thrombosis and Haemostasis
MedicineHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy